A novel CAP score, combining type-IV collagen, albumin, and prothrombin time, effectively predicts 180-day surgery-related mortality in liver resection for hepatocellular carcinoma. With a predictive accuracy (AUC: 0.728), the score identifies risk levels in patients, showing mortality rates of 0.8% for low risk to 26.7% for high risk. It outperforms other existing models, underscoring its potential as a vital tool in preoperative assessment.
Journal Article by Hayakawa T, Miyashita S (…) Aoki T et 8 al. in Ann Surg Oncol
© 2025. The Author(s).